These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 30190781)

  • 1. Current status of imaging in nonalcoholic fatty liver disease.
    Li Q; Dhyani M; Grajo JR; Sirlin C; Samir AE
    World J Hepatol; 2018 Aug; 10(8):530-542. PubMed ID: 30190781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiologic evaluation of nonalcoholic fatty liver disease.
    Lee SS; Park SH
    World J Gastroenterol; 2014 Jun; 20(23):7392-402. PubMed ID: 24966609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current and Emerging Biomarkers and Imaging Modalities for Nonalcoholic Fatty Liver Disease: Clinical and Research Applications.
    Hydes T; Brown E; Hamid A; Bateman AC; Cuthbertson DJ
    Clin Ther; 2021 Sep; 43(9):1505-1522. PubMed ID: 34400007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of Non-alcoholic Fatty Liver Disease (NAFLD): Current Concepts.
    Papatheodoridi M; Cholongitas E
    Curr Pharm Des; 2018; 24(38):4574-4586. PubMed ID: 30652642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance imaging for the assessment of pathological hepatic findings in nonalcoholic fatty liver disease.
    Imajo K; Honda Y; Yoneda M; Saito S; Nakajima A
    J Med Ultrason (2001); 2020 Oct; 47(4):535-548. PubMed ID: 33108553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of imaging and recent developments in diagnosis of nonalcoholic fatty liver disease.
    Koplay M; Sivri M; Erdogan H; Nayman A
    World J Hepatol; 2015 Apr; 7(5):769-76. PubMed ID: 25914777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: new trends and role of ultrasonography.
    Tada T; Nishimura T; Yoshida M; Iijima H
    J Med Ultrason (2001); 2020 Oct; 47(4):511-520. PubMed ID: 33089412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MR elastography is effective for the non-invasive evaluation of fibrosis and necroinflammatory activity in patients with nonalcoholic fatty liver disease.
    Costa-Silva L; Ferolla SM; Lima AS; Vidigal PVT; Ferrari TCA
    Eur J Radiol; 2018 Jan; 98():82-89. PubMed ID: 29279175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum cytokeratin-18 and its relation to liver fibrosis and steatosis diagnosed by FibroScan and controlled attenuation parameter in nonalcoholic fatty liver disease and hepatitis C virus patients.
    Darweesh SK; AbdElAziz RA; Abd-ElFatah DS; AbdElazim NA; Fathi SA; Attia D; AbdAllah M
    Eur J Gastroenterol Hepatol; 2019 May; 31(5):633-641. PubMed ID: 30839434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonalcoholic fatty liver disease: Noninvasive methods of diagnosing hepatic steatosis.
    AlShaalan R; Aljiffry M; Al-Busafi S; Metrakos P; Hassanain M
    Saudi J Gastroenterol; 2015; 21(2):64-70. PubMed ID: 25843191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance imaging and transient elastography in the management of Nonalcoholic Fatty Liver Disease (NAFLD).
    Han MA; Saouaf R; Ayoub W; Todo T; Mena E; Noureddin M
    Expert Rev Clin Pharmacol; 2017 Apr; 10(4):379-390. PubMed ID: 28277807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in noninvasive methods for diagnosing nonalcoholic fatty liver disease.
    Shen FF; Lu LG
    J Dig Dis; 2016 Sep; 17(9):565-571. PubMed ID: 27429213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance.
    Schwenzer NF; Springer F; Schraml C; Stefan N; Machann J; Schick F
    J Hepatol; 2009 Sep; 51(3):433-45. PubMed ID: 19604596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How to Diagnose Nonalcoholic Fatty Liver Disease.
    de Alwis NM; Anstee QM; Day CP
    Dig Dis; 2016; 34 Suppl 1():19-26. PubMed ID: 27547937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and Evaluation of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Including Noninvasive Biomarkers and Transient Elastography.
    Tsai E; Lee TP
    Clin Liver Dis; 2018 Feb; 22(1):73-92. PubMed ID: 29128062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New advances in diagnosis of nonalcoholic fatty liver disease].
    Qu Y; Lu L
    Zhonghua Gan Zang Bing Za Zhi; 2016 Feb; 24(2):85-8. PubMed ID: 26983472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease.
    Castera L; Friedrich-Rust M; Loomba R
    Gastroenterology; 2019 Apr; 156(5):1264-1281.e4. PubMed ID: 30660725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiologic Imaging in Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.
    Esterson YB; Grimaldi GM
    Clin Liver Dis; 2018 Feb; 22(1):93-108. PubMed ID: 29128063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography.
    Imajo K; Kessoku T; Honda Y; Tomeno W; Ogawa Y; Mawatari H; Fujita K; Yoneda M; Taguri M; Hyogo H; Sumida Y; Ono M; Eguchi Y; Inoue T; Yamanaka T; Wada K; Saito S; Nakajima A
    Gastroenterology; 2016 Mar; 150(3):626-637.e7. PubMed ID: 26677985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Elastography in Non-Alcoholic Fatty Liver Disease.
    Constantinescu C; SĂndulescu L; SĂftoiu A
    Curr Health Sci J; 2020; 46(3):255-269. PubMed ID: 33304627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.